A Protocol for the Preparation of Cryoprecipitate and Cryodepleted Plasma

Methods in Molecular Biology

Volumn 728, Issue , 2011, Pages 259-265

  Sparrow, Rosemary L ^a   Greening, David W ^b   Simpson, Richard J ^b  

^a AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^b NONE

Author keywords

Antihemophilic factor; Cryodepleted; Cryoprecipitate; Cryosupernatant; Factor VIII; Fibrinogen; Plasma; Proteomics

Indexed keywords

PLASMA PROTEIN;

ANALYSIS; ARTICLE; BLOOD SAMPLING; FREEZING; HUMAN; PRECIPITATION;

ANALYTIC SAMPLE PREPARATION METHODS; BLOOD PROTEINS; BLOOD SPECIMEN COLLECTION; CHEMICAL PRECIPITATION; FREEZING; HUMANS;

EID: 79960138203     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-068-3_17     Document Type: Chapter

References (18)

1. Pool, J.G., E.J. Gershgold, and A.R. Pappenhagen (1964), High-Potency Antihaemophilic Factor Concentrate Prepared from Cryoglobulin Precipitate. Nature. 203, 312.
2. Pool, J.G. (1965), Preparation and testing of antihemophilic globulin (Factor 8) sources for transfusion therapy in hemophilia. Description of a new sterile concentrate process for blood banks. Scand J Clin Lab Invest. 17, p. Suppl 84, 70–7.
3. Callum, J.L., K. Karkouti, and Y. Lin (2009), Cryoprecipitate: the current state of knowledge. Transfus Med Rev. 23(3), 177–88.
4. Erber, W.N. and D.J. Perry (2006), Plasma and plasma products in the treatment of massive haemorrhage. Best Pract Res Clin Haematol. 19(1), 97–112.
5. Mason, E.C. (1978), Thaw-siphon technique for production of cryoprecipitate concentrate of factor VIII. Lancet. 2(8079), 15–7.
6. Rock, G.A. and P. Tittley (1979), The effects of temperature variations on cryoprecipitate. Transfusion. 19(1), 86–9.
7. Rock, G.A., W.H. Cruickshank, E.S. Tackaberry, et al. (1979), Improved yields of factor VIII from heparinized plasma. Vox Sang. 36(5), 294–300.
8. Shanbrom, E. and W.J. Owens (2001), A novel method to enhance the formation of cryoprecipitate from fresh plasma. Blood. 98, 60a.
9. Yousef, H., D. Neurath, M. Freedman, et al. (2006), Cryoprecipitate production: the use of additives to enhance the yield. Clin Lab Haematol. 28(4), 237–40.
10. , American Association of Blood Banks. Technical Manual. 23rd ed, ed. M. Bethesda.
11. Wensley, R.T. and T.J. Snape (1980), Preparation of improved cryoprecipitated factor VIII concentrate. A controlled study of three variables affecting the yield. Vox Sang. 38(4), 222–8.
12. Meilin, E., S. Sela, and B. Kristal (2008), Heparin cryoprecipitation reduces plasma levels of non-traditional risk factors for atherosclerosis in vitro. Blood Purif. 26(3), 238–48.
13. , Menitove J. 5.7.5.14 Standards of Blood Banks and Transfusion Services. American Association of Blood Banks. .ed 23rd, ed. M.D. Bethesda. U.S.A. 30.
14. Prowse, C. (2009), Properties of pathogen-inactivated plasma components. Transfus Med Rev. 23(2), 124–33.
15. Cardigan, R., K. Philpot, P. Cookson, et al. (2009), Thrombin generation and clot formation in methylene blue-treated plasma and cryoprecipitate. Transfusion. 49(4), 696–703.
16. Hornsey, V.S., O. Drummond, A. Morrison, et al. (2009), Pathogen reduction of fresh plasma using riboflavin and ultraviolet light: effects on plasma coagulation proteins. Transfusion. 49(10), 2167–72.
17. George, J.N., E.B. Pickett, and R. Heinz (1986), Platelet membrane microparticles in blood bank fresh frozen plasma and cryoprecipitate. Blood. 68(1), 307–9.
18. McVerry, B.A. and S.J. Machin (1979), Incidence of allo-immunization and allergic reactions to cryoprecipitate in haemophilia. Vox Sang. 36(2), 77–80.